Growth hormone axis
Hexarelin
Also called Examorelin, EP-23905
per administration
A human trial worked out how much to take and how often, so a dosing schedule is shown.
Work out your draw
These numbers are a starting point — change any of them.
- Concentration
- 1.67mg/mL
- Volume per draw
- 0.06mL
- Units to dial
- 6
- Doses per cartridge
- 50
Requested 0.063 mL
Requested 6.3
6.3 units is between clicks. The nearest setting is 6, which delivers 100 mcg instead of 105 mcg.
Vial label
Copy this into your label printer.
Published research contexts for Hexarelin describe 105–210 mcg per administration. Descriptive only, not a recommendation.
About 55 minutes; longer-acting than GHRP-2 or GHRP-6 but still short.
Dosing schedule
How Hexarelin is commonly stepped up, for reference only.
These are commonly-discussed research protocols shared for educational reference. This is not medical advice and is not a substitute for guidance from a qualified professional.
| Phase | Amount | Frequency | Route |
|---|---|---|---|
| Reported dose-response rangeThe amounts Imbimbo's dose-response study administered; the higher step gave a larger growth-hormone rise. A short-acting secretagogue. | 1.5–3 mcg/kg (about 105–210 mcg for a 70 kg adult) | Once daily | SubQ |
Modelled level — every day
1× is the peak after a single dose.
- Steady-state peak
- 1.00× single dose
- Time to steady state
- 5hours
- Administrations
- 7/ week
Read off the modelled curve, not an even-interval formula
About five half-lives
Where these numbers come from
- Imbimbo BP et al., JCEM 1994;78:693A subcutaneous dose-response study of hexarelin at 1.5–3 mcg/kg, with growth-hormone release rising across the range in healthy volunteers.